News & Updates
Filter by Specialty:
Fenofibrate staves off vision loss in diabetes
The antilipidemic drug fenofibrate averts or delays diabetic retinopathy (DR) in diabetes patients with early retinal changes in the LENS trial, potentially paving the way for the least invasive route of drug delivery in this population.
Fenofibrate staves off vision loss in diabetes
08 Aug 2024
Nearly half of dementia cases preventable by tackling 14 risk factors
Nearly half of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors starting from childhood, including two new risk factors – high LDL-cholesterol (LDL-C) level and untreated vision loss – according to a report of the 2024 Lancet Commission on dementia.
Nearly half of dementia cases preventable by tackling 14 risk factors
01 Aug 2024
IOP fluctuation does not predict visual field progression in glaucoma
A recent study has found no evidence supporting the association of intraocular pressure (IOP) fluctuation, as measured in clinical practice, with visual field (VF) progression in patients with glaucoma.
IOP fluctuation does not predict visual field progression in glaucoma
30 Jul 2024
Personalized faricimab dosing shows durable efficacy in nAMD
A treat-and-extend personalized treatment with faricimab based on disease activity results in sustained gains in vision or anatomic outcomes through 2 years in patients with neovascular age-related macular degeneration (nAMD), reports a study. Moreover, nearly four in five (80 percent) patients have achieved extended dosing intervals of 12 weeks or more.
